- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Mangalam Drugs & Organics has informed of a delay in submitting its unaudited financial results for the quarter ended September 30, 2025. The company cited "unavoidable circumstances" preventing finalization. It will make sincere efforts to complete the results as soon as possible, with a Board meeting intimation to follow for approval.